Viatris (VTRS) EPS (Basic) (2019 - 2026)
Viatris (VTRS) posted EPS (Basic) of -$0.1 for Q2 2026, down 166.89% on a QoQ basis from $0.15 in Q1 2026, and down 2504.14% year-over-year from $0.0 in Q2 2025.
Analysis
Viatris (VTRS) EPS (Basic) (2019 - 2026) Analysis & Trends
Viatris has reported EPS (Basic) for 8 years, with the latest figure at -$0.1 in Q2 2026.
- On a quarterly basis, EPS (Basic) fell 2504.14% year-over-year to -$0.1 in Q2 2026; TTM through Jun 2026 was -$0.35, a 88.06% increase from a year earlier, with the FY2025 full-year figure at -$3.02, down 467.98% from the prior year.
- EPS (Basic) was -$0.1 for Q2 2026 at Viatris, down from $0.15 in the prior quarter.
- The five-year high for EPS (Basic) was $0.83 in Q4 2022, with the low at -$2.55 in Q1 2025.
- Average EPS (Basic) over 5 years is -$0.09, with a median of $0.09 recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) soared 482.28% in 2022, then sank 2777.04% in 2025.
- Over 5 years, EPS (Basic) stood at $0.83 in 2022, then slumped by 176.46% to -$0.64 in 2023, then surged by 32.15% to -$0.43 in 2024, then soared by 32.52% to -$0.29 in 2025, then surged by 65.03% to -$0.1 in 2026.
- The last three EPS (Basic) figures came in at -$0.1 (Q2 2026), $0.15 (Q1 2026), and -$0.29 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn | -0.49 |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | -0.10 |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 0.06 |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 0.22 |
| 5 | Bausch Health Companies | 2.36 Bn | 518.87 Mn | 2.10 Bn | 0.69 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -0.23 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 1.17 |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn | 0.70 |
| 9 | Fennec Pharmaceuticals | 405.56 Mn | 364.31 Mn | 17.15 Mn | 0.06 |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.10 |
| Mar 31, 2026 | 0.15 |
| Dec 31, 2025 | -0.29 |
| Sep 30, 2025 | -0.11 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | -2.55 |
| Dec 31, 2024 | -0.43 |
| Sep 30, 2024 | 0.08 |
| Jun 30, 2024 | -0.27 |
| Mar 31, 2024 | 0.10 |
| Dec 31, 2023 | -0.64 |
| Sep 30, 2023 | 0.28 |
| Jun 30, 2023 | 0.22 |
| Mar 31, 2023 | 0.19 |
| Dec 31, 2022 | 0.83 |
| Sep 30, 2022 | 0.29 |
| Jun 30, 2022 | 0.26 |
| Mar 31, 2022 | 0.33 |
| Dec 31, 2021 | -0.22 |
| Sep 30, 2021 | 0.26 |